<p>(A) Differentiated THP-1 cells infected with Mtb H37Rv bearing a luciferase-reporting plasmid were treated with various concentrations of NTZ or TIZ for the indicated times. Intracellular Mtb was measured as luciferase activity at 24, 48 and 72 h. (B) Infected THP-1 cells were treated as in (A) but after 24 h treatment the drugs were removed and cells were incubated with medium without drug. Luciferase activity was measured at 24 h, 48 h (24 h post-wash) and 72 h (48 h post-wash). (C) Differentiated THP-1 cells were exposed to various concentrations of NTZ, TIZ or rapamycin for 4 h. Endogenous LC3 processing (using LC3 antibodies) and mTORC1 activity were determined by immunoblotting as in <a href="http://www.plospathogens.org/article/in...
<p>MGMT-deficient U87 cells or U87 cells engineered to over-express MGMT (U87+MGMT) were incubated w...
<p>(A–B) Cell proliferation assay. Cells were treated with 1, 10, 30, 50 and 100 µM concentrations o...
<p><b>A</b> Cell cycle analysis of 5TGM1 cells treated with 0, 200 or 400 nM of MTM. Cells were trea...
<p>Peripheral blood mononuclear cells isolated from healthy human subjects and infected with Mtb H37...
<p>(A) HEK293T, HMEC, BT549, MDA-MB-468, U2OS and A2780 cells were plated (5000 cells/well) in 96 we...
<p>(A) Cells were incubated with 10 µM NTZ or 10 µM TIZ for the indicated times. (B) Cells were incu...
<p>SKM-1 and SKM-1R cells were exposed to 5 nM BTZ for 24 h and the viable cell number was evaluated...
<p>Cells with co-treatment of MTX and lutein, or pretreated with lutein for 2 or 24 hrs were measure...
<p>Representative images of (A) U87-MG and U–SC, and (B) L0627 morphology after 48 h treatment with ...
<p>Normal (HaCaT) and tumor cells (HeLa, T98G and U118)were treated with different TMZ concentration...
<p>(A) Cytotoxicity of TMZ on BEAS-2B cells after 24 hours as measured using the MTT assay. Data rep...
<p>RAW 264.7 cells were (<b>A</b>) exposed to Type II and Type III mutants of PAO1 for 1 h, or (<b>B...
<p>(<b>A</b>) The indicated cell lines were assessed for viability on the indicated days using CellT...
1. Proliferation rate has been measured in TECs derived from AB (#3147), B2 (#3146) and B2/ B3 (#314...
<p>IEC-6 cells were treated with (A) different concentration of MTX (0, 0.01, 0.1, 1, 10 and 100 μM)...
<p>MGMT-deficient U87 cells or U87 cells engineered to over-express MGMT (U87+MGMT) were incubated w...
<p>(A–B) Cell proliferation assay. Cells were treated with 1, 10, 30, 50 and 100 µM concentrations o...
<p><b>A</b> Cell cycle analysis of 5TGM1 cells treated with 0, 200 or 400 nM of MTM. Cells were trea...
<p>Peripheral blood mononuclear cells isolated from healthy human subjects and infected with Mtb H37...
<p>(A) HEK293T, HMEC, BT549, MDA-MB-468, U2OS and A2780 cells were plated (5000 cells/well) in 96 we...
<p>(A) Cells were incubated with 10 µM NTZ or 10 µM TIZ for the indicated times. (B) Cells were incu...
<p>SKM-1 and SKM-1R cells were exposed to 5 nM BTZ for 24 h and the viable cell number was evaluated...
<p>Cells with co-treatment of MTX and lutein, or pretreated with lutein for 2 or 24 hrs were measure...
<p>Representative images of (A) U87-MG and U–SC, and (B) L0627 morphology after 48 h treatment with ...
<p>Normal (HaCaT) and tumor cells (HeLa, T98G and U118)were treated with different TMZ concentration...
<p>(A) Cytotoxicity of TMZ on BEAS-2B cells after 24 hours as measured using the MTT assay. Data rep...
<p>RAW 264.7 cells were (<b>A</b>) exposed to Type II and Type III mutants of PAO1 for 1 h, or (<b>B...
<p>(<b>A</b>) The indicated cell lines were assessed for viability on the indicated days using CellT...
1. Proliferation rate has been measured in TECs derived from AB (#3147), B2 (#3146) and B2/ B3 (#314...
<p>IEC-6 cells were treated with (A) different concentration of MTX (0, 0.01, 0.1, 1, 10 and 100 μM)...
<p>MGMT-deficient U87 cells or U87 cells engineered to over-express MGMT (U87+MGMT) were incubated w...
<p>(A–B) Cell proliferation assay. Cells were treated with 1, 10, 30, 50 and 100 µM concentrations o...
<p><b>A</b> Cell cycle analysis of 5TGM1 cells treated with 0, 200 or 400 nM of MTM. Cells were trea...